BRCA1 and ovarian cancer: With continued advancements in high-throughput technologies, some genetic alterations associated with ovarian cancer, such as specific mutations in KRAS, loss-of-function mutations in PTEN, mutations in TP53, modifications in BRCA1/2, and changes in homologous recombination genes, have been uncovered [23].